Actively Recruiting
Hepatic Safety of Statin Use in Neurology Inpatients
Led by Shanghai Yueyang Integrated Medicine Hospital · Updated on 2024-09-19
2000
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research employs a cross-sectional study and a retrospective cohort study to analyze the liver safety of statin use among inpatients in the neurology department in China from different perspectives. The aim is to supplement evidence-based medicine and provide guidance for the clinical use of statins.
CONDITIONS
Official Title
Hepatic Safety of Statin Use in Neurology Inpatients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized in the Department of Neurology of Yueyang Hospital from June 2020 to February 2023
- Age 18 to 85 years old, both sexes
- Diagnosed with cerebrovascular disease, headache disease, or dizziness and vertigo according to ICD-11 codes
You will not qualify if you...
- Incomplete medical history
- Prior statin use for less than 7 days before admission
- Patients with malignant tumors or hematological diseases based on ICD-11 codes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Yueyang Integrated Medicine Hospital
Shanghai, Shanghai Municipality, China
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here